CAMK2G and cardiac hypertrophy: While trans-cinnamaldehyde, the main active compound in CC, has been shown to alleviate cardiac hypertrophy and fibrosis through ERK inhibition, CaMKII modulation, and correction of Ca2+ handling [49], our findings raise concerns about the cardiotoxicity of its DMSO-soluble fraction.